chr2-47369506-A-G

Variant summary

Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1_StrongPS1_ModeratePM2PP5_Very_Strong

The NM_002354.3(EPCAM):​c.1A>G​(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000103 in 1,549,840 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000011 ( 0 hom. )

Consequence

EPCAM
NM_002354.3 start_lost

Scores

5
6
5

Clinical Significance

Likely pathogenic criteria provided, multiple submitters, no conflicts P:3

Conservation

PhyloP100: 1.31
Variant links:
Genes affected
EPCAM (HGNC:11529): (epithelial cell adhesion molecule) This gene encodes a carcinoma-associated antigen and is a member of a family that includes at least two type I membrane proteins. This antigen is expressed on most normal epithelial cells and gastrointestinal carcinomas and functions as a homotypic calcium-independent cell adhesion molecule. The antigen is being used as a target for immunotherapy treatment of human carcinomas. Mutations in this gene result in congenital tufting enteropathy. [provided by RefSeq, Dec 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 16 ACMG points.

PVS1
Start lost variant, next in-frame start position is after 6 pathogenic variants. Next in-frame start position is after 69 codons. Genomic position: 47373828. Lost 0.217 part of the original CDS.
PS1
Another start lost variant in NM_002354.3 (EPCAM) was described as [Pathogenic] in Lovd
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 2-47369506-A-G is Pathogenic according to our data. Variant chr2-47369506-A-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 1801655.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EPCAMNM_002354.3 linkc.1A>G p.Met1? start_lost Exon 1 of 9 ENST00000263735.9 NP_002345.2 P16422

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EPCAMENST00000263735.9 linkc.1A>G p.Met1? start_lost Exon 1 of 9 1 NM_002354.3 ENSP00000263735.4 P16422

Frequencies

GnomAD3 genomes
AF:
0.00000658
AC:
1
AN:
152082
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000133
AC:
2
AN:
150630
Hom.:
0
AF XY:
0.0000120
AC XY:
1
AN XY:
83022
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000446
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000159
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000107
AC:
15
AN:
1397758
Hom.:
0
Cov.:
31
AF XY:
0.0000159
AC XY:
11
AN XY:
690930
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000114
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000552
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000658
AC:
1
AN:
152082
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74298
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000378
ExAC
AF:
0.0000174
AC:
2

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Gastric cancer Pathogenic:1
Jul 01, 2021
Laboratory for Genotyping Development, RIKEN
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: research

- -

EPCAM-related disorder Pathogenic:1
Aug 29, 2023
PreventionGenetics, part of Exact Sciences
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The EPCAM c.1A>G variant is predicted to disrupt the translation initiation site (Start loss). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0045% of alleles in individuals of South Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-47596645-A-G). Other predicted loss-of-function variants have been reported nearby (see, for example, Cheema et al. 2020. PubMed ID: 33083013; Zhu et al. 2020. PubMed ID: 33240318). This variant is interpreted as likely pathogenic. -

Familial cancer of breast Pathogenic:1
Dec 17, 2024
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The EPCAM c.1A>G variant is predicted to disrupt the translation initiation site (Start loss) and loss-of-function is a known mechanism of disease . This variant has not been reported in the literature. This Variant not found in gnomAD. In silico prediction tools (PolyPhen, SIFT , M-CAP , CADD ,MetaRNN, BayesDel addAF and MutPred ) support its disease causing variant . Therefore, it has been classified as likely pathogenic variant . Pathogenic/likely pathogenic heterozygous variants in the EPCAM gene cause autosomal dominant Lynch syndrome 8 (OMIM # 613244) which has Incomplete penetrance -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.27
D
BayesDel_noAF
Pathogenic
0.28
CADD
Benign
20
DANN
Benign
0.95
DEOGEN2
Benign
0.19
T;.
Eigen
Uncertain
0.29
Eigen_PC
Uncertain
0.24
FATHMM_MKL
Benign
0.53
D
LIST_S2
Uncertain
0.90
D;D
M_CAP
Pathogenic
1.0
D
MetaRNN
Pathogenic
0.99
D;D
MetaSVM
Uncertain
0.086
D
PROVEAN
Benign
-1.4
N;N
REVEL
Uncertain
0.58
Sift
Pathogenic
0.0
D;D
Sift4G
Uncertain
0.028
D;D
Polyphen
0.92
P;.
Vest4
0.86
MutPred
1.0
Loss of glycosylation at P3 (P = 0.0682);Loss of glycosylation at P3 (P = 0.0682);
MVP
0.72
ClinPred
0.99
D
GERP RS
4.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.95
gMVP
0.53

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs752808238; hg19: chr2-47596645; API